All posts by imreal

Pharmacy Delivery Leader NowRx Announces Decathlon Capital Investment


NowRx is a business built for the rapid transition to a delivery economy, but the dramatic and lasting changes caused by the coronavirus pandemic has shifted customer behavior even more quickly than anticipated.

NowRx, a leading, same-day pharmacy delivery company experiencing rapid growth during the coronavirus pandemic, has accepted a multi-million investment from revenue-based financing firm Decathlon Capital Partners.

NowRx will use the $3 million investment to scale its popular pharmacy model and meet the increased demand caused by the continuing coronavirus pandemic. Specifically, the investment will be used to open up new geographic territories and add new capacity in existing markets.

Same-day prescription delivery demand has surged as pharmacy customers, many of whom have underlying health conditions or are elderly, choose to skip the pharmacy lines in favor of quick, convenient and safe doorstep delivery. NowRx is uniquely positioned to meet that new demand.

“NowRx is a business built for the rapid transition to a delivery economy, but the dramatic and lasting changes caused by the coronavirus pandemic has shifted customer behavior even more quickly than anticipated,” said NowRx CEO and Co-founder Cary Breese. “Decathlon’s investment helps us expand more rapidly to meet these customers’ needs and continue scaling the pharmacy of the future.”

Decathlon Capital’s funding is non-dilutive, meaning that the Palo Alto-based revenue-based finance firm takes no equity from NowRx shareholders or founders in exchange fro the investment. Instead, the investment is paid back from future revenue in flexible installments scaled to the company’s revenue growth.

“As we talked with NowRx it became clear that a revenue-based funding model was the perfect fit,” said John Borchers, managing partner for Decathlon Capital Partners. “Decathlon’s capital will fuel NowRx’s growth without requiring them to turn over ownership or control.”

NowRx relies on leading logistics, ordering and fulfillment technology to bring down delivery times, lower the cost of fulfilment and ensure the highest level of customer service. The company develops and deploys proprietary technology to reshape the $400 billion pharmacy industry just like DoorDash, Instacart and other delivery services have transformed food delivery and grocery-buying habits.

“Industry-leading technology and superior customer service have been the backbone of NowRx’s success,” said NowRx Co-founder and Chief Technology Officer Sumeet Sheokand. “With Decathlon Capital’s support, we’re thrilled to bring the NowRx pharmacy experience to new customers across the nation.”

About NowRx

NowRx is a leading same-day pharmacy delivery service based in Mountain View, Calif. Founded in 2015, the company has delivered over 150,000 prescriptions to more than 18,000 customers. Learn more at https://www.nowrx.com/.

About Decathlon Capital Partners

Decathlon Capital Partners provides growth capital for companies seeking alternatives to traditional equity investment. Through the use of highly customized revenue-based financing solutions, Decathlon provides long-term growth capital without the dilution, loss of control and operational overhead that often comes with equity-based funding. With offices in Palo Alto and Park City, Decathlon is the largest revenue-based funding investor in the U.S. and is active across a wide range of sectors. Learn more at https://decathloncapital.com/.

Share article on social media or email:

Ulrich Barn Builders Announces Additions to Leadership Team


Ulrich Barn Builders of Texas, a leader in shed manufacturing, announces five key additions to its leadership team.

Ulrich is excited to announce the appointment of Chris Pendergrass as its new President effective July 1, 2019. Chris comes with 20 years experience in manufacturing and 10 years of full P&L responsibility, leading family owned manufacturing businesses through double digit growth, lean driven cost reductions and culture/leadership transitions. Real world experience along with an education including a BA in Chemistry from Austin College, a BS in Chemical Engineering from Washington University in St. Louis and a MBA from the McCombs School of Business at The University of Texas at Austin, gives Chris the foundation to effectively lead and grow Ulrich into the future. Chris is an active member of YPO and serves on the Manufacturing Excellence Network board.

After serving as interim Chief Financial Officer since October 2019, Ken Hensley has been appointed CFO effective February 3, 2020. Ken received a MBA from Southern Methodist University and brings over 30 years of accounting, finance and operations experience to Ulrich. He is a strategic and tactical accounting leader who has guided companies through acquisition and continuous improvement initiatives.

Brad Egan, the new Head of Sales, is a talented and creative leader that has a skill for bringing rhyme and reason to chaos. Over the years, Brad successfully elevated the sales and marketing efforts for multiple companies in construction services and manufacturing sectors – each time resulting in exponential sales growth and increased market share. Brad earned his degree from Texas Wesleyan University in Fort Worth, Texas and holds several industry certifications.

Luis Santamaria has been at Ulrich for almost two years and was originally hired in 2018 as the Manager of Retail Operations before transitioning into Head of Operations in October 2019. Luis is a mechanical engineer with an MBA from the University of Texas at San Antonio and lean manufacturing certification. His addition to Ulrich’s leadership team brings over 10 years experience in manufacturing and process improvement.

Verlin Yoder has been with Ulrich since 2008 when he began building sheds and playhouses. He quickly rose through the ranks to his current position of Vice President of Technology. Verlin was asked to join the leadership team in January 2020. With over a decade of experience working in various departments at Ulrich, Verlin’s addition to the leadership team brings an understanding of history and insight while we look at future growth and development.

CEO Jonathan Ulrich said of his new leadership team, “these five stood apart as individuals who can take my vision from an idea and execute it into reality. We are at a point where strong leadership is vital to the continued growth and success of Ulrich and Chris, Ken, Brad, Luis and Verlin bring the operational and leadership skills needed for these roles. Ulrich is fortunate to have individuals of their caliber on our team and we are excited for the future.”

For more than a decade, Ulrich’s focus has been to transition from a commodity storage/shed manufacturer into a “lifestyle structures” company. This approach has allowed us to address the customers’ deepest and most important dreams, needs and goals on every project instead of simply providing them a space that may not be suited for its desired use long term. This allows us to co-design a functional long term solution for families to live a more memorable life as we push into a post-COVID-19 world.

Ulrich Barn Builders is a leading manufacturer of storage sheds and lifestyle structures such as cabin shells, playhouses, and finished cabins. To be the leading manufacturer in backyard storage structures, Ulrich has made customer satisfaction a priority throughout each phase of the customer experience. To find out more information about us visit http://www.UlrichBarns.com, http://www.UlrichCabins.com, http://www.UlrichGarages.com.

Share article on social media or email:

Definitive Healthcare Develops COVID-19 Re-Opening Analysis Index


News Image

“As an organization, we remain committed to being a powerful part of the solution during the COVID-19 crisis by sharing our data, maps, and deep analytics with the governmental departments, organizations, providers, and clients who need them most,” said Jason Krantz, CEO of Definitive Healthcare.

Definitive Healthcare, the leading provider of data, intelligence, and analytics on the healthcare provider market, today announced that it has developed a COVID-19 Re-Opening Analysis Index, which predicts safe re-opening timelines at a state and county level. This new interactive, visual Tableau dashboard takes into account multiple factors such as flattening trends in COVID-19 cases and positive testing, compliance with stay-at-home guidelines, re-opening decisions, and the role they play in timelines.

“As an organization, we remain committed to being a powerful part of the solution during the COVID-19 crisis by sharing our data, maps, and deep analytics with the governmental departments, organizations, providers, and clients who need them most to help support the needs of communities worldwide during this pandemic,” said Jason Krantz, founder and CEO of Definitive Healthcare. “Today’s Re-Opening Predictive Analysis Index is one in a series of predictive indices designed to enable appropriate resourcing, timely decision-making, and a safe migration back to community and professional settings as stay-in-place restrictions begin to lift. Last month, we developed the COVID-19 Capacity Predictor, which assessed regional capacity, based on hospital ICU bed and ventilator availability against local populations and the rate of Covid-19 spread. In the coming weeks, we look forward to launching our next predictive index, which will be focused on the short-term prognosis for the return of elective surgeries by region, by facility, and by practitioner.”

As an industry-leading healthcare data, analytics, and intelligence organization, Definitive Healthcare has driven essential industry analyses for nearly a decade – using its comprehensive and proprietary datasets to create current and predictive views of the healthcare provider market. Now, in the time of COVID-19, Definitive Healthcare has continued this work in the form of a series of predictive, free-to-the-public visual tools that help government officials, organizations, and providers understand and address the pandemic. Last month, the company announced their COVID-19 Capacity Predictor, designed to predict where US hospitals may become overwhelmed with regard to mechanical ventilators and ICU beds. Today’s indicator is designed to provide re-opening predictions, enabling governments, organizations and companies make the best and right decisions for the businesses, people, hospitals, and communities they serve.

Definitive Healthcare’s predictive dashboards have also been widely used for critical decision making by the Department of Defense and the Department of Human Services – and integrated into CNN’s 411 Coronavirus Resource page, Amazon Web Service’s COVID-19 data lake, Esri’s COVID-19 GIS Hub, and more.

Definitive Healthcare sought to integrate relevant information for evaluating state and county COVID-19 profiles for re-opening. To create this new dashboard, Definitive Healthcare’s data science team combined its own comprehensive base of proprietary hospital data (total number of beds, licensed beds, ICU beds, ventilator capacity) with external public resources that show trending cases, deaths, and testing counts – including the IHME model, Johns Hopkins University data, The COVID Tracking Project, the Rt (effective reproduction rate) model, The New York Times, the United States Census Bureau, and overlaid with stay-at-home orders by state. Definitive Healthcare’s analysis is being provided free to the public to help address the growing pandemic.

Users of Definitive Healthcare’s COVID-19 Re-Opening Analysis Index can filter to a state or county of interest. Based on the filters a user applies, information is provided about the total cumulative number of cases and deaths, the total percentage of the population that’s been tested so far, and the effective reproduction rate (Rt) to show how many people will be infected from one infected person, on average. Seven-day rolling averages are graphed to also depict the number of total tests given, positive tests reported, and deaths per day – to highlight any potential downward trends.

View Definitive Healthcare’s COVID-19 Re-Opening Analysis Index here. This map is dynamic – updated on the Definitive Healthcare website in real time through live data feeds and modified as relevant data sources become available. For a video walk-through of the new dashboard, please watch the replay of Definitive Healthcare’s latest webinar.

Share article on social media or email:

Fidelity Capital Provides First Quarter Rundown and 2020 Outlook


Fidelity Capital has been riding a wave of growth for some time now, and while the pandemic does threaten to damage some industries, we continue to see positive signs for continued growth in the rest of the year for equipment leasing.

Fidelity Capital, a leading provider of a wide variety of lending services, released its First Quarter Rundown for the first several months of 2020.

Based on the numbers in the first quarter of the year, Fidelity Capital looks to position itself for another big year of growth. The company doubled its internal line in 2019 for leasing equipment across the country, with major industries including technology, medical, biotech and manufacturing accounting for about 80 percent of its current portfolio. However, there has also been a big growth in the transportation space in the first quarter, due in part to increased demand caused by the COVID-19 pandemic.

“Fidelity Capital has been riding a wave of growth for some time now, and while the pandemic does threaten to damage some industries, we continue to see positive signs for continued growth in the rest of the year for equipment leasing,” said Alan Eppstein, Account Executive at Fidelity Capital. “We are encouraged to see signs of strong performance for the rest of 2020.”

Fidelity Capital’s president projects the internal line will double with new business for the year. The company’s goal is to expand its application-only limits along with other programs to help customers. The executive team sees the potential for growth in all sectors of technology equipment leasing, transportation financing, manufacturing equipment leasing and biotech equipment leasing.

Despite the pandemic, the firm remains fully staffed and prepared to handle all requests for leasing and financing of equipment to companies across the nation in a wide variety of industries.

“There has been a lot of market volatility this year due to the pandemic, but there remains a steady demand for equipment leasing and financing services,” said Eppstein. “We remain committed to providing outstanding service to all of our clients and to get them the financing and leasing they need even in the midst of these unprecedented times.”

For more information about Fidelity Capital and its services, visit the company’s website, http://www.fidelitycapitalonline.com.

Share article on social media or email:

Germ-Fogger™ High Efficiency Disinfecting System Launches


The Germ-Fogger™ Dual Head High Volume Disinfecting System

The Germ-Fogger™ Dual Head High Volume Disinfecting System

Today’s world has a rapidly expanding need for decontamination of large surfaces and spaces. The impressive performance of the Germ-Fogger™ makes it a great option for a wide variety of these applications.

The Germ-Fogger™ is an American-made disinfecting-fogger with NEW vortecular™ technology designed to efficiently sanitize all types of surfaces. It’s unique dual-head design makes it the most productive disinfecting agent sprayer currently available.

The ability to rapidly and efficiently disinfect a wide variety of buildings and outdoor venues has become a critical part of maintaining work spaces that are safe and secure for employees and the public. The need for mass disinfection of large areas is large now and will expand further in the near future. The Germ-Fogger makes this disinfection process a lot easier and more cost effective.

Business Re-Invention Driven By Market Demand

“Germ-Fogger™ is not our first rodeo,” states Thad Fisco, President of Portland Kettle Works, a world leading manufacturer of high tech stainless steel craft brewing and beverage systems. “Since 2010 we’ve sold and installed 100’s of craft breweries all around the world. Experts in equipment manufacturing, we began looking at expanding into manufacturing equipment to efficiently and quickly decontaminate breweries, bars and tap rooms. We spoke with friends in disinfectant, facilities maintenance, and contract cleaning businesses. We studied concepts, and recommendations on proper disinfection techniques. We experimented with innovative design concepts and the Germ-Fogger was born!”

“Our initial plan is to just offer Germ-Fogger™ to support our existing craft brewery and beverage clients. From there we plan expand into more general market for disinfecting and decontamination equipment. The expanding need for decontamination, combined with the impressive performance of the Germ-Fogger make this a natural expansion product line for us.”

Designed To be Easy-to-Use, Strong and Durable

“One of our principal design goals for the Germ-Fogger™ was to make an easy to use industrial grade product designed for fast disinfecting agent delivery, easy maintenance and long use life,” continues Fisco. “We did this by using the same high strength aircraft grade aluminum, stainless steel and brass components we use in our brewery equipment. Mounted on a rolling cart, except for hoses the Germ-Fogger has no plastic parts yet it is compact, lightweight, easy to maneuver and strong enough to stand up to many years of heavy commercial use.”

Germ-Fogger™ is ideal for precision bulk disinfection of all categories of commercial, industrial and government facilities including:


  • Floors
  • Countertops
  • Walls
  • Restrooms
  • Locker rooms
  • Aircraft cabins
  • School buses
  • Train cars
  • Restaurants
  • Bars
  • Daycare facilities
  • Schools
  • Offices
  • And all other high-touch areas…

Two Heads Are Better Than One

The Germ-Fogger’s patent pending design incorporates a number of features to make it the best disinfecting agent delivery system available today. One of its most innovative features is its ability to supply one or two disinfecting wands off a single disinfecting agent tank. The Germ-Fogger comes standard with one disinfecting wand. Easily user installed, the second wand can be ordered at the same time or added later. With two wands the Germ-Fogger can disinfect over 52,000 sq. ft. per hour – that’s well over one acre (43,600 sq. ft.) and about 90% of a standard football field including the end zones (57,600 ft. sq.)!

Other Germ-Fogger™ Features

The Germ-Fogger’s design also incorporates a number of additional features to make it the best disinfecting agent delivery system available today.

  • High Quality Construction – The Germ-Fogger is built from machined aluminum, stainless steel and brass parts, all easily serviceable. In normal use it will provide you with years of trouble free service.
  • Ergonomic Atomizing Wand Design – the palm fitting grips of the Germ-Fogger atomizing wands are comfortable to hold and a gentle squeeze on the trigger unleashes the fogging spray.
  • High Capacity – the Germ-Fogger’s disinfecting agent tank holds five full gallons (18.9L) of disinfecting agent allowing it to cover up to 52,000 sq. ft. on a single filling. And with dual head use this can be covered in less than an hour!
  • Quick Change – the Germ-Fogger’s disinfecting agent tank uses stainless steel quick disconnecting fittings. This allows you to swap tanks in a matter of seconds and continue spraying with minimal down time. Extra tanks can be pre-filled and kept ready for rapid use.
  • Safely Extended Spray Tip – the Germ-Fogger’s precision brass spray tip is almost 10” from the operator’s hand to minimize operator exposure to disinfecting agents. And the spray tip is connected with a quick disconnect fitting for rapid exchange.
  • Easy to Use – once you’ve aimed the sprayer a gentle squeeze on the ergonomic pistol grip trigger is all it takes to start the spray.
  • Right- or Left-handed Operation – The Germ-Fogger™ spraying wand is completely ambidextrous.

Price and Availability

The Germ-Fogger™ has a suggested retail price of $5,850.00 and has a three-year limited warranty. More information is available at https://www.germ-fogger.com/ or email info@germ-fogger.com. It is in pilot production now, scheduled to begin shipping June 1, 2020, and currently available for pre-ordering at the website.

Share article on social media or email:

Global Tech Company NTT Selects PlateSmart as Vehicle Recognition Vendor


“As industry visionaries and leading innovators of ALPR technologies, our innovative products will now be used to serve NTT and their clients’ needs on a global basis.” – John Chigos, CEO, PlateSmart

PlateSmart Technologies, which applies cutting-edge AI and deep learning technologies to its automatic license plate recognition (ALPR)-based vehicle recognition solutions, announced it was selected by NTT Corporation (NTT) to be an official provider of ALPR, vehicle recognition and safety solutions for customers of the global technology and business solutions provider.

“NTT is a leading global innovator when it comes to applying IT and technology around the world,” said John Chigos, CEO, PlateSmart. “This relationship will further extend our global reach beyond the 30-plus countries we are in currently and will allow us to expand into sectors we are not already in. This agreement between our companies also serves as further proof that our products are the best of breed in the industry.”

NTT, which operates in more than 80 countries and regions, will partner with PlateSmart to generate sensor information and video management details for the company’s Accelerate Smart data platform, which is being deployed in cities around the world to help improve the lives of citizens through smart technologies.

“So many opportunities exist for the use of our ALPR-based vehicle recognition solutions around the world,” Chigos said. “As industry visionaries and leading innovators of ALPR technologies, our innovative products will now be used to serve NTT and their clients’ needs on a global basis.”

PlateSmart Technologies was the first industry player to introduce a software-only, camera-agnostic automatic license plate recognition (ALPR) engine powered by early AI-based object recognition technology — a major industry milestone positioning the company as an industry innovator. In 2015, PlateSmart was also the first to introduce an HD ALPR-based vehicle recognition solution capable of capturing license plate data as well as vehicle make and color.

PlateSmart currently offers proactive, real-time solutions to law enforcement agencies that are used to prevent and solve crimes and prevent acts of terrorism. The company also provides its solutions across a large spectrum of commercial clients, ranging from smart cities to government users to educational facilities, to enhance any perimeter or access control security solution. Airports, rental car companies and retailers have also benefited from using PlateSmart vehicle recognition technology for enhanced customers service, improved security, and loss and fraud prevention.

The company is also in development with players in the franchise food business, and its software is currently deployed for testing with one of the largest restaurant chains in the country to improve customer support and provide contactless payment. PlateSmart anticipates that such technology will be in ever more demand in the wake of the COVID-19 crisis.

For more information about PlateSmart solutions, visit http://www.platesmart.com.

About PlateSmart®

In business since 2004, PlateSmart Technologies was the first industry player to introduce a software-only, camera-agnostic automatic license plate recognition (ALPR) engine powered by early AI-based object recognition technology and compatible with both state-of-the-art cameras and video management systems (VMS). PlateSmart offers both mobile and fixed-location solutions, which are designed either to function as stand-alone tools or to integrate with third-party software and hardware. PlateSmart ARES®, the company’s enterprise solution, provides real-time actionable intelligence with license plate number, state jurisdiction, and vehicle make recognition for complete situational awareness. PlateSmart’s solutions are the recipients of multiple industry awards for excellence in security technology. http://www.platesmart.com

FORWARD LOOKING STATEMENTS: This press release may contain forward-looking statements and/or predictions. These statements are based on history, current knowledge, and current market conditions. They are subject to change without notice as conditions and knowledge change; therefore, undue reliance should not be placed on such statements.

Share article on social media or email:

Inventory Optimization Solutions (IOS) Announces Red Hills Surgical Center has Received Q1 2020 Best Practice Award


“We wanted more control of supply chain processes, and when we implemented Envi, it was to gain greater management of supplies, ordering, pricing, invoice matching and inventory.” — Dan Stannard, Red Hills Surgical Center

Inventory Optimization Solutions (IOS) is pleased to announce Red Hills Surgical Center has received the Q1 2020 Best Practice Award. Red Hills has demonstrated outstanding capabilities in using the Envi® solution to create greater automation and improve end-to-end supply chain processes, ultimately reducing manual work and saving staff time. IOS continually identifies and shares best practices from customers to help educate the healthcare community on supply chain automation. Each quarter, IOS recognizes an organization demonstrating supply chain excellence.

The Red Hills Surgical Center provides patient-centered, compassionate and leading edge outpatient surgical procedures performed by 35 local physicians in a 17,000 square foot multi-specialty ambulatory surgery center. Red Hills Surgical Center is fully accredited through the Accrediting Association for Ambulatory Health Care (AAAHC), allowing the organization to measure the quality of services and performance against nationally recognized standards. Not only is the organization recognized for clinical excellence, the IOS Best Practice award recognizes their exceptional performance in supply chain management.

Supply Chain Improvement Goals

Dan Stannard, administrator, Red Hills Surgical Center, set specific goals to improve their supply chain processes holistically. “Before implementing Envi, we were operating in two separate systems, and realized interoperability between our procurement and inventory management processes, and our existing surgical software solution, was vitally important. We recognized the need for a solution that provided the integration, while also supporting our goals around case costing, inventory management and price management.”

Stannard and the Red Hills team focused their efforts on the development of a completely automated, end-to-end supply management system. “We wanted more control of supply chain processes, and when we implemented Envi, it was to gain greater management of supplies, ordering, pricing, invoice matching and inventory,” said Stannard. “We looked at our entire supply chain, then set about improving automation and management of processes, and reducing manual workarounds.”

Best Practice Improvements

By integrating Envi with their existing surgical software and maintaining laser focus on their goal of automation, Red Hills Surgical Center has achieved a growing list of new efficiencies. Specific best practices include:


  • Integration between Envi and Red Hills’ legacy surgical software solution, increasing automation for clinicians and staff members, and building new efficiencies and visibility to procedures and patients
  • Greater control over supply chain processes, including item management, ordering, pricing, invoice matching and inventory
  • Using the Envi mobile app for purchase order approval, keeping supply orders on time and on track
  • Leveraging 3-way price match consistently to ensure correct invoice payments
  • Reducing the frequency of ordering, and maintaining lower levels of on-hand inventory, with better visibility to supplies and increased control over timing of orders and shipments
  • Standardizing contract pricing to manage spend, gaining greater value from both GPO and local contracts
  • Reducing manual workarounds to save staff time
  • Improving item master management – as an ASC, the Red Hills team continuously adds new items. With Envi, duplications are avoided and it’s easy to identify where the same or similar items are already in use
  • Implementing physical counting, which leverages Envi to print out location-specific physical count lists, supporting location-specific counts and supporting overall inventory management

Recognizing the Community of Healthcare Users Improving Supply Chain Processes

IOS works with more than 5,000 healthcare facilities throughout the United States. As a result of this large footprint and broad range of users, IOS continually identifies, documents and shares best practices designed to help healthcare organizations improve their supply chain processes and overall results.

“Our team is proud to help organizations like Red Hills achieve supply chain success,” said Steve Britt, President, IOS. “It’s an honor to share the stories of supply chain excellence from our community of Envi users. Red Hills is a great example of a team that goes the extra mile, by making sure systems are integrated for data sharing and automation, and looking at their supply chain as an interconnected system. By connecting and automating processes at every step, they’ve improved business performance, and in turn, help their clinicians stay focused on what matters most – delivering patient care.”

# # #

About Inventory Optimization Solutions (IOS)

Inventory Optimization Solutions (IOS) provides healthcare organizations with powerful, cost-effective, uniquely modular, and easy-to-use web-based supply chain solutions that offer the flexibility to support facilities throughout the continuum of care. IOS operates with a commitment to delivering world-class customer service, guiding customers to a better supply chain, providing high-touch support, industry best-practices, deep healthcare expertise and continuously evolving solutions that help them succeed. The goal of IOS is to ensure customers have more time each day for their most important role: caring for patients. For more information, visit http://www.ioscorp.com.

Share article on social media or email:

Multi-Billion Dollar Potential Market for COVD-19 Vaccine, Per Market Research Firm


Kalorama Information logo

Only 45% of US adults tend to get the flu shot, depending on the severity of the flu season. Presumably, many more will rush to get the COVID-19 vaccine, and we expect more attention on flu as well because of the attention on respiratory disease transmission.

As the COVID-19 outbreak advances worldwide, companies are stepping up to the challenge to develop a potential vaccine. There are over 75 confirmed COVID-19 vaccine candidates, five of which have already entered clinical trials. In its recent report on vaccine development, Kalorama Information, part of Science and Medicine Group, has tracked companies that are developing vaccines for COVID-19. The firm says that a vaccine for COVID-19 would create a market worth billions in revenue, perhaps even as much as ten billion, but that companies would also incur large R&D spends and production challenges which have always keep profit margins in the industry on the low side. Kalorama has covered vaccines in market research studies for two decades.

Vaccination protects not only individuals, but also entire communities from diseases spread by person-to-person transmission. When immunization programs achieve high levels of “community” immunity, the likelihood that an infected person will transmit the disease to a susceptible individual is greatly reduced. Vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related complications in the elderly. Pharmacoeconomic studies have demonstrated the value of influenza and pneumococcal vaccines; however, despite various vaccination campaigns and promotional efforts, immunization rates for these diseases continue to be low in the elderly population.

In the U.S., for example, the Centers for Disease Control (CDC) has found that Influenza is responsible for 20,000 to 40,000 deaths annually, and up to 50,000 deaths and an estimated 200,000 excess hospitalizations at a cost of $750 million to $1 billion during epidemic years. Also mortality from all pneumococcal disease, also vaccine-mitigatable, results in about 40,000 deaths annually, with morbidity estimated at 500,000 cases of pneumonia.

“Only 45% of US adults tend to get the flu shot, depending on the severity of the flu season,” said Bruce Carlson, Publisher of Kalorama Information. “Presumably, many more will rush to get the COVID-19 vaccine, and we expect more attention on flu as well because of the attention on respiratory disease transmission.”

Influenza vaccines generated $5.1 billion in revenues. Sales fluctuate from year to year with a variety of factors including new influenza strains and outbreaks, government contracts and stockpiling, new production formats and rising demand in developing countries affecting demand.

Roughly estimated market demand based on comparison to flu vaccine alone, Kalorama believes the market for COVID-19 could be 8-10 billion dollars in its first full year of implementation. It would represent a quarter of the vaccine market in that year.

“But there will likely be many factors that would move that number up or down,” said Carlson. “Price, supply, government intervention, stockpiling effects all could temporarily create a very large or smaller than expected market.”

Carlson also noted that such a vaccine could start out at a high market figure and then in the future settle down to a more stable number as it becomes standard and as competition is introduced, which has been the case with cervical cancer, travel and flu vaccines.

Many vaccine trials are underway, some for diseases such as breast cancer, HIV, and malaria. But because of the nature of the severity of the COVID-19 pandemic, vaccine manufacturers are prioritizing the development of COVID-19 vaccines. As of April 20, 2020, several candidates for a COVID-19 vaccine are showing promise:


  • CanSino Biologics is developing a vaccine for the prevention of COVID-19, Ad5-nCoV, a recombinant vaccine incorporating the adenovirus type 5 vector. On March 8, 2020, CanSino received approval from the Chinese authorities to begin human trials. This is the first coronavirus vaccine to advance to phase II trials.
  • Moderna offers its mRNA-1273, a novel lipid nanoparticle-encapsulated mRNA vaccine encoding for a perfusion-stabilized form of the SARS-CoV-2 spike protein. On March 16, 2020, the company began its phase I open-label, dose-ranging trial, occurring at Kaiser Permanente Washington Health Research Institute in Seattle. The company says it has applied for Phase II.
  • Inovio Pharmaceuticals announced that CEPI provided a grant to develop a vaccine against COVID-19 called INO-4800. The company is collaborating with Beijing Advaccine Biotechnology to advance the product. Preclinical testing has begun, with human clinical trials to commence in April 2020 in the U.S., China, and South Korea. It is anticipated that with positive results, some 1 million doses of the INO-4800 DNA vaccine can be produced by the end of 2020. On April 6, 2020, the company received approval to begin phase I trials. The Bill and Melinda Gates Foundation, along with other nonprofits, is supporting Inovio’s COVID-19 vaccine project.
  • Shenzhen Geno-Immune Medical Institute offers the LV-SMENP-DC vaccine. The LV-SMENP-DC vaccine is made by modifying dendritic cells (DC) with lentivirus vectors expressing COVID-19 minigene SMENP and immune-modulatory genes. CTLs will be activated by LV-DC presenting COVID-19 specific antigens. The project is in phase I.
  • Shenzhen Geno-Immune Medical Institute has a second product — the COVID-19/aAPC vaccine. The COVID-19/aAPC vaccine is prepared by applying lentivirus modifications, including immune-modulatory genes and the viral minigenes, to the artificial antigen-presenting cells (aAPCs). It is also in phase I.

Many vaccine trials are underway, some for diseases such as breast cancer, HIV, and malaria. But because of the nature of the severity of the COVID-19 pandemic, vaccine manufacturers are prioritizing the development of COVID-19 vaccines. As of April 20, 2020, several candidates for a COVID-19 vaccine are showing promise including CanSino, Moderna, Inovio and others. Kalorama Information’s vaccine production report is available at: https://kaloramainformation.com/product/vaccine-development-and-production-trends-covid-19-and-other-vaccines-pipeline/.

About Kalorama Information

For more than 30 years, Kalorama Information has been a leading publisher of market research in healthcare areas, including in vitro diagnostics (IVD), biotechnology, healthcare, medical devices, and pharmaceuticals.

Share article on social media or email:

Tinuiti doubles down on Over The Top (OTT) advertising and expands Connected TV (CTV) capabilities to reflect changing consumer behavior


Tinuiti, the largest independent performance marketing agency across the triopoly of Google, Facebook and Amazon, expands its OTT practice with the introduction of Tinuiti’s OTT-Native Approach. The agency has hired Jesse Math as vice president of client strategy, planning and platforms—this enhanced approach offers clients access to established one-to-one relationships with publishers and gives OTT customers the flexibility to find the most beneficial mix along with transparency into every dollar spent.

“Jesse’s extensive knowledge and passion for the possibilities of OTT make him the perfect person to lead our agency and clients into the future of video and OTT,” said Craig Atkinson, Tinuiti’s chief client officer. “I can’t think of a better person to architect the future of our video offering.”

This newly established position continues to fortify Tinuiti’s dedication to building a leadership team consisting of forward-thinking, performance-driven experts. A digital veteran of 14 years, Math joins Tinuiti from another performance marketing agency where he most recently served as vice president of Paid Media, taking the lead on Paid Social and OTT. His experience in the field bolsters Tinuiti’s already impressive OTT and CTV offerings to clients.

“The ability to target specific audiences and measure results, across the immense scale of OTT, positions the channel, not just for awareness but as a performance driver,” said Jesse Math. “Expanding Tinuiti‘s ‘OTT-Native Approach’ offers clients TV-like reach in TV-like content on the largest screen in the house to achieve all performance marketing goals: Awareness, Growth & Profit. Our focus on quality, transparency, and frequency is truly differentiated.”

Tinuiti’s evolved OTT offering is a unified extension of the agency’s growing programmatic video and Amazon DSP practices. The addressability of OTT coupled with Tinuiti’s programmatic offering delivers a truly unified solution that successfully drives both brand and performance outcomes through data-driven personalized experiences.

About Tinuiti

Tinuiti is the largest independent performance marketing agency across the Triopoly of Google, Facebook, Amazon and beyond. With expert knowledge in search, social, Amazon & marketplaces, mobile apps, CRM & email marketing and more, every solution is built on best-in-class analytics with brilliant creative delivered by exceptional strategists. Tinuiti’s cross-channel expertise helps clients identify and acquire customers, then retain or reactivate audiences throughout the digital journey. Clients include Bombas, Truist (formerly known as BB&T), Eddie Bauer, Ethan Allen, Etsy, Jet.com, Rite Aid, Seventh Generation, The Honest Company, Tommy Bahama, Terminix, Vitamin Shoppe. For more information visit http://www.tinuiti.com.

Share article on social media or email:

Tipton Health Communications Guides Organization’s Toward the “New Normal” With Additional Webinars


As healthcare organizations continue to navigate and push forward through the challenges of the COVID-19 pandemic, attention is slowly starting to focus on what the “new normal” will look like in the months ahead as team members return to the workplace and hospitals resume elective procedures. To support the transition, Tipton Health Communications has added two additional webinars focused on preparing and adjusting for life in a COVID-19 world.

The webinars will be held on June 2 and June 9. For more information and to register, please visit tiptonhealth.com/webinars.

Employee Communications Essentials in the “New Normal” Hospital Environment

June 2, 12:30 – 1 p.m. EDT

Erin DiGirolamo, MPH, senior manager of Internal Communications and Digital Workforce Strategy at the Children’s Hospital of Philadelphia, and Phil Ellingsworth Jr., strategic communications manager at Tipton Health Communications, will discuss the best practices for nurse communications in a hospital environment forever changed by the pandemic.

How Nurse Autonomy Helped Hospitals Manage the Crisis (and Will Help Build the New Normal)

June 9, 12:30 – 1 p.m. EDT

Judi Hahn, director of Professional Practice and Nursing Education at Yale New Haven Hospital, will outline how nurse autonomy and nursing professional governance was key to helping hospitals manage the COVID-19 crisis. She also will touch on how autonomous nurses will help build the “new normal” of healthcare after the pandemic is behind us.

Tipton Health Communications continues to add webinars that try to help make sense of a complex world following the pandemic.

For more information on these upcoming webinars and the experts leading them, please visit tiptonhealth.com/webinars. Here you can also view recordings of our past sessions.

About Tipton Health Communications

Tipton Health Communications is a leading provider of executive nurse consulting and mentoring; nursing excellence program development; and Magnet®, Pathway to Excellence® and Practice Transition Accreditation Program™ consulting support to the nation’s hospital and healthcare systems. In addition, Tipton Health supports clients nationwide with award-winning communications services, including employee communications, human resources communications, public relations, marketing communications, intranet and Internet design, graphic design, and strategic communications. For more information, please visit tiptonhealth.com.

Tipton Health Communications products and services are neither sponsored nor endorsed by the ANCC. ANCC Magnet Recognition®, ANCC National Magnet Conference®, Institute for Credentialing Innovation®, Magnet®, Magnet Recognition Program®, The Magnet Prize® and Pathway to Excellence® Program are registered trademarks of the American Nurses Credentialing Center. Journey to Magnet Excellence™ and Pathway to Excellence in Long Term Care™ are trademarks of the American Nurses Credentialing Center.

Share article on social media or email: